Value in new medicines and longer strides, page-51

@kyriaco agree in the sense that my biggest losses have been 'lost opportunity' cost from selling too early eg XRO, ZIP, ZNO, AVH was in for 100k$ for the latter two at circa .15c for both - the opportunity lost cost has been close to $1mil for each

on the flip side for investors that aren't Soph's eg I sold AVH to help out one of our family businesses pay it's OPEX during a start up phase (now profitable). competing obligations....

ive found if I trade and free carry then the likelihood of being in the company for the 're-rate event' increases considerably for eg in either AVH or ZNO I would have made min 100-200k and have shares still for when dividends eventually get paid

trading also helps the liquidity in the stock - imho there are multiple strategies that suit different investors at different points in their lives and the trading strategies can be complementary to all investors without everyone having to adopt the same approach